ENTPD1 and myeloid sarcoma: This might be due to the effects of T cell receptor (TCR) ligation on CD39 activity, since it only becomes catalytically active in Tregs after TCR activation15, which would be expected in circulating Treg cells from RR-MS patients suffering an exacerbation, but not in healthy subjects.